Abstract:An increase in SP‐A and SP‐D amount has been seen in the moderate COVID‐19, but in the severe stages of the disease due to the destruction of type 2 alveolar cells, which are the main producers of surfactants, these amounts will be reduced. Background Severe cases of COVID‐19 often lead to the development of acute respiratory syndrome, a critical condition believed to be caused by the harmful effects of SARS‐CoV‐2 on type II alveolar cells. These cells play a crucial role in producing pulmonary surfactants, which are essential for proper lung function. Specifically focusing on surfactant proteins, including Surfactant protein A (SP‐A), Surfactant protein B, Surfactant protein C, and Surfactant protein D (SP‐D), changes in the levels of pulmonary surfactants may be a significant factor in the pathological changes seen in COVID‐19 infection. Objective This study aims to gain insights into surfactants, particularly their impacts and changes during COVID‐19 infection, through a comprehensive review of current literature. The study focuses on the function of surfactants as prognostic markers, diagnostic factors, and essential components in the management and treatment of COVID‐19. Finding In general, pulmonary surfactants serve to reduce the surface tension at the gas–liquid interface, thereby significantly contributing to the regulation of respiratory mechanics. Additionally, these surfactants play a crucial role in the innate immune system within the pulmonary microenvironment. Within the spectrum of COVID‐19 infections, a compelling association is observed, characterized by elevated levels of SP‐D and SP‐A across a range of manifestations from mild to severe pneumonia. The sudden decline in respiratory function observed in COVID‐19 patients may be attributed to the decreased synthesis of surfactants by type II alveolar cells. Conclusion Collectin proteins such as SP‐A and SP‐D show promise as biomarkers, offering potential avenues for predicting and monitoring pulmonary alveolar injury in the context of COVID‐19. This clarification enhances our understanding of the molecular complexities contributing to respiratory complications in severe COVID‐19 cases, providing a foundation for targeted therapeutic approaches using surfactants and refined clinical management strategies.

Role of surfactant-associated protein A in lung injury due to drowning

Determination of Serum Pulmonary Surfactant Protein A and Its Significance in Patients with Acute Lung Injury

Immunoregulatory function of SP-A

Unraveling the enigma: The emerging significance of pulmonary surfactant proteins in predicting, diagnosing, and managing COVID‐19

Changes in Pulmonary Surfactant after Acute Lung Injury Induced by Oleic Acid

Phospholipid Changes of Pulmonary Surfactant in Rats with Pulmonary Edema after Seawater Drowning

The value of surfactant protein a in evaluating the severity and prognosis in community-acquired pneumonia patients

The clinical significance of plasma surfactant protein-D in patients with septic ARDS

Impact of acute stress disorder on surfactant protein D levels in acute lung injury

Effect of recruitment maneuver on pulmonary surfactant in young piglets with acute lung injury

Regulatory roles of SP-A and exosomes in pneumonia-induced acute lung and kidney injuries

Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity

The Role of Aquaporin-1 (AQP1) Expression in a Murine Model of Lipopolysaccharide-Induced Acute Lung Injury

Effects of Pulmonary Surfactant in Adult Patients with Acute Lung Injury/Acute Respiratory Distress Syndrome:A Meta-analysis

Manipulating the Air-Filled Zebrafish Swim Bladder As a Neutrophilic Inflammation Model for Acute Lung Injury

Immunohistochemical investigation of pulmonary surfactant-associated protein A in fatal poisoning

Effects of Surfactant Protein A on Lipopolysaccharide-Induced Interleukin-6 Expression in Human Renal Tubular Epithelial Cells

Genetic Susceptibility to Acute Lung Injury

The Changes of Coagulation and Fibrinolysis System in Acute Lung Injury/acute Respiratory Distress Syndrome

The protective effect of different airway humidification liquids to lung after tracheotomy in traumatic brain injury: The role of pulmonary surfactant protein-A (SP-A)

Study of Acute Lung Injury after Intestinal Ischemia-Reperfusion in Rats